{"id":109602,"title":"hVIVO PLC (AIM:HVO) Notice of Results","publisher":"Share Talk","author":"sharetalk","published":"2023-08-24T06:28:53+00:00","modified":"2023-08-24T06:28:53+00:00","canonical_url":"https://www.share-talk.com/hvivo-plc-aimhvo-notice-of-results-2/","markdown_url":"https://www.share-talk.com/hvivo-plc-aimhvo-notice-of-results-2.md","json_url":"https://www.share-talk.com/hvivo-plc-aimhvo-notice-of-results-2.json","category":"Healthcare","categories":["Healthcare","Pharmaceutical"],"tags":["Andrew Catchpole","antiviral","breast cancer","Cathal Friel","CHIMagents","clinical respiratory drug","Codagenix","COVID-19","Dengue Fever","Dr Andrew Catchpole","Dr Chris Chiu","Gregory Stoloff","hVIVO","Imperial College London","Imutex Ltd","laboratory","Malaria","Open Orphan","ORPH","Oxford BioTherapeutics","pharmaceutical","quarantine clinic","Rahim Fandi","Share Talk","The Lancet","Vaccine","virology","West Nile Virus","Zika"],"featured_image":"https://i0.wp.com/www.share-talk.com/wp-content/uploads/2023/11/Stencil-Google-Chrome-2023-04-19-at-2.47.43-PM.jpeg?fit=1231%2C615&quality=89&ssl=1","format":"news","language":"en-GB","content":"**hVIVO plc (AIM & Euronext: HVO),** the world leader in testing infectious and respiratory disease products using human challenge clinical trials, announces that it will release its interim results for the six months ended 30 June 2023 on Tuesday 12 September 2023.\n\n**Investor presentation**\n\nYamin ‘Mo’ Khan, Chief Executive Officer, and Stephen Pinkerton, Chief Financial Officer, will provide a live presentation relating to the interim results via the Investor Meet Company platform on Tuesday 12 September 2023 at 18:00 BST.\n\nThe presentation is open to all existing and potential shareholders. Questions can be submitted pre-event via your Investor Meet Company dashboard up until 9 a.m. the day before the meeting or at any time during the live presentation.\n\nInvestors can sign up to Investor Meet Company for free and add to meet hVIVO [here](https://www.investormeetcompany.com/hvivo-plc-1/register-investor). Investors who already follow hVIVO on the Investor Meet Company platform will automatically be invited.\n\nFor further information please contact:\n\nhVIVO plc\n\n+44 (0) 20 7756 1300\n\nYamin ‘Mo’ Khan, Chief Executive Officer\n\nStephen Pinkerton, Chief Financial Officer"}